Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from MAIA frailty subgroup analysis: long-term follow-up with daratumumab plus lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma. Local targets link to admitted publications; unresolved targets remain external evidence.
10.4049/jimmunol.1003032
10.4049/jimmunol.1003032 · 2011 · External reference
10.1182/blood.v124.21.3474.3474
10.1182/blood.v124.21.3474.3474 · 2014 · External reference
10.1080/19420862.2015.1007813
10.1080/19420862.2015.1007813 · 2015 · External reference
10.4049/jimmunol.1501351
10.4049/jimmunol.1501351 · 2016 · External reference
10.1182/blood-2015-12-687749
10.1182/blood-2015-12-687749 · 2016 · External reference
10.1002/cyto.a.23693
10.1002/cyto.a.23693 · 2019 · External reference
10.1038/s41375-020-0855-4
10.1038/s41375-020-0855-4 · 2021 · External reference
10.1016/s1470-2045(21)00466-6
10.1016/s1470-2045(21)00466-6 · 2021 · External reference
10.1016/s0140-6736(19)32956-3
10.1016/s0140-6736(19)32956-3 · 2020 · External reference
10.1016/s1470-2045(24)00282-1
10.1016/s1470-2045(24)00282-1 · 2024 · External reference
10.1056/nejmoa2312054
10.1056/nejmoa2312054 · 2024 · External reference
10.1038/s41591-024-03485-7
10.1038/s41591-024-03485-7 · 2025 · External reference
Unresolved reference
External reference
10.1056/nejmoa1817249
10.1056/nejmoa1817249 · 2019 · External reference
10.1038/s41375-024-02505-2
10.1038/s41375-024-02505-2 · 2025 · External reference
10.1038/s41375-019-0539-0
10.1038/s41375-019-0539-0 · 2020 · External reference
10.1182/blood-2014-12-615187
10.1182/blood-2014-12-615187 · 2015 · External reference
10.3324/haematol.2012.075051
10.3324/haematol.2012.075051 · 2013 · External reference
10.1038/s41375-021-01488-8
10.1038/s41375-021-01488-8 · 2022 · External reference
10.1016/j.clml.2021.06.005
10.1016/j.clml.2021.06.005 · 2021 · External reference
10.1200/jco.2019.37.15_suppl.8027
10.1200/jco.2019.37.15_suppl.8027 · 2019 · External reference
10.1182/bloodadvances.2020001965
10.1182/bloodadvances.2020001965 · 2020 · External reference
10.1038/s41375-020-0713-4
10.1038/s41375-020-0713-4 · 2020 · External reference
10.1111/ejh.14392
10.1111/ejh.14392 · 2025 · External reference
10.1016/s1470-2045(25)00280-3
10.1016/s1470-2045(25)00280-3 · 2025 · External reference
10.1182/blood.2020009507
10.1182/blood.2020009507 · 2021 · External reference
10.1016/s2152-2650(25)03425-1
10.1016/s2152-2650(25)03425-1 · External reference
10.1038/s41408-023-00843-5
10.1038/s41408-023-00843-5 · 2023 · External reference
10.1182/blood.2024025868
10.1182/blood.2024025868 · 2025 · External reference
10.1186/s13045-024-01569-y
10.1186/s13045-024-01569-y · 2024 · External reference
10.1097/bs9.0000000000000208
10.1097/bs9.0000000000000208 · 2024 · External reference
